Tempus CEO and Co-Founder, Eric Lefkofsky, Will Improve Cancer Treatment With Tempus’ Technology

Today, Eric Lefkofsky is an entrepreneur with a technology background and very successful career as an entrepreneur. He is also an avid philanthropist and is motivated to help others and give back to the community. His latest company will help him achieve just that by aiding cancer patients with better treatments through his Tempus technology. Eric Lefkofsky co-founded Tempus Brad Keywell, a longtime friend, and colleague of Eric’s. To date, Eric has many successful business ventures, including Echo Global, InnerWorkings, and Groupon, all of which have contributed to his massive fortune.

The biggest challenges for Eric and Tempus when it comes to improving cancer treatments is the organization of massive amounts of raw clinical data. Tempus will be using the latest technology in analytics and learning software to create algorithms for sorting all of the genomic and molecular data that Tempus accumulates. Once organized, the data collected by Tempus will directly accessible to physicians and doctors around the world who can then utilize the data to provide their patients with better cancer treatment. Another aspect of Tempus is the RNA and DNA sequencing of compiled data from different locations.

The profound effect Tempus could have on the healthcare industry is tremendous, and the large amounts of data collected so far is a testament to that. Most of the database in place are unstructured and contained within databases that cannot transfer data in the same patterns. WIth many small and isolated databases that cannot organize their information together, overall usefulness of such data becomes limited. Eric Lefkofsky aims to fix this problem with Tempus as a database that holds all information and sorts it to be readily used through sophisticated software.

Cancer is a very serious disease because it is so complex and varied, making it hard to treat. Some patients respond well to certain treatments, while others do not. Some patients even respond very negatively to certain treatments. Eric knew a better system was possible with his background in technology, which is why he co-founded Tempus in the first place. Helping patients receive better treatment more personalized to their needs will increase treatment effectiveness for many people.

Eric Lefkofsky’s Facebook Page: www.facebook.com/eplefkofsky/

Leave a Reply